Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

Radiotherapy and Oncology

Volumn 67, Issue 3, 2003, Pages 339-344

  Bentzen, Lise ^a   Keiding, Susanne ^a   Nordsmark, Marianne ^a   Falborg, Lise ^a   Hansen, Søren B ^a   Keller, Johnny ^a   Nielsen, Ole S ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

18F fluoromisonidazole; Hypoxia; Oxygenation; pO2; Positron emission tomography; Soft tissue sarcomas

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORINE 18; MISONIDAZOLE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; HISTOGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MALE; MALIGNANT NEOPLASTIC DISEASE; OXYGEN ELECTRODE; POLAROGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; TISSUE OXYGENATION; TUMOR DIAGNOSIS;

EID: 0038642530     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00081-1     Document Type: Article

References (28)

1. 18F]Fluoro-2-deoxy-D-glucose. Acta Oncol. 39:2000;629-637.
2. 2 electrode measurements. Influence of tumour volume and carbogen breathing. Acta Oncol. 41:2002;304-312.
3. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
4. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003; (in press).
5. 2 on tumour oxygenation in advanced head and neck tumours. Radiother Oncol. 66:2003;71-74.
6. Evans S.M., Hahn S.M., Magarelli D.P., et al. Hypoxia in human intraperitoneal and extremity sarcomas. Int J Radiat Oncol Biol Phys. 49:2001;587-596.
7. Fyles A., Milosevic M., Hedley D., et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol. 20:2002;680-687.
8. Grau C., Overgaard J. Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. Radiother Oncol. 13:1988;301-309.
9. Gray L.H., Conger A.D., Ebert M., Hornsey S., Scott O.C.A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 26:1953;638-648.
10. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 26:1993;45-50.
11. Koh W.J., Bergman K.S., Rasey J.S., et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys. 33:1995;391-398.
12. Koh W.J., Rasey J.S., Evans M.L., et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys. 22:1992;199-212.
13. 18F]fluoroerythronitroimidazole PET. J Nucl Med. 42:2001;1643-1652.
14. Moulder J.E., Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys. 10:1984;695-712.
15. Nordsmark M., Alsner J., Keller J., et al. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br J Cancer. 84:2001;1070-1075.
16. Nordsmark M., Bentzen S.M., Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol. 33:1994;383-389.
17. Nordsmark M., Keller J., Nielsen O.S., Lundorf E., Overgaard J. Tumour oxygenation assessed by polarographic needle electrodes and bioenergetic status measured by 31P magnetic resonance spectroscopy in human soft tissue tumours. Acta Oncol. 36:1997;565-571.
18. Nordsmark M., Loncaster J., Chou S.C., et al. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int J Radiat Oncol Biol Phys. 49:2001;581-586.
19. Nordsmark M., Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol. 57:2000;39-43.
20. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 41:1996;31-39.
21. Nordsmark M, Loncaster J, Aquino-Parsons C, et al. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol 2003; (in press).
22. Piert M., Machulla H., Becker G., et al. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia. Eur J Nucl Med. 26:1999;95-109.
23. Rasey J.S., Casciari J.J., Hofstrand P.D., Muzi M., Graham M.M., Chin L.K. Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole. Radiat Res. 153:2000;84-92.
24. Rasey J.S., Grunbaum Z., Magee S., et al. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat Res. 111:1987;292-304.
25. 18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys. 36:1996;417-428.
26. Rasey J.S., Nelson N.J., Chin L., Evans M.L., Grunbaum Z. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat Res. 122:1990;301-308.
27. Rischin D., Peters L., Hicks R., et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol. 19:2001;535-542.
28. Yeh S.H., Liu R.S., Wu L.C., et al. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma. Eur J Nucl Med. 23:1996;1378-1383.